AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LEVODROPROPIZINE

10 registrations across 3 African markets— 10 active

Markets with LEVODROPROPIZINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
HACTOSEC
Syrup
🇰🇪KenyaDAFRA PHARMA GMBHactiveSept 2027
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaDAFRA PHARMA GMBHactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaMACLEODS PHARMACEUTICA LS LTDactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaMACLEODS PHARMACEUTICA LS LTDactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaDAFRA PHARMA GMBHactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaMACLEODS PHARMACEUTICA LS LTDactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaDAFRA PHARMA GMBHactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaMACLEODS PHARMACEUTICA LS LTDactive
LEVODROPROPIZINE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaDAFRA PHARMA GMBHactive
HACTOSEC
sirop / 6 mg / 6ml
🇸🇳SenegalDAFRA PHARMAactive

LEVODROPROPIZINE in Africa — Regulatory Overview

LEVODROPROPIZINE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Kenya, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.